Phlow
  • About
    • Who We Are
    • Our Impact
    • Leadership
    • Careers
  • CDMO
  • Product Portfolio
  • U.S. Facilities
    • Industrial Footprint
    • SAPIR™
  • News
  • Collaborate
Select Page

Phlow Corp. Closes $20 Million Series A Financing to Further Essential Medicines Research and Development Programs and Advanced Manufacturing Initiatives

2021, Press Releases, Updates From Phlow™

Pioneering essential medicines company seeks to actively accelerate U.S. manufacturing for medicines at risk of shortage, including those for COVID-19 pandemic response Source: BUSINESS WIRE RICHMOND, Va.– Phlow Corp., a public benefit corporation committed to a...

Congresswoman Spanberger Tours Phlow Corp, Focuses on Strengthening Domestic Supply Chain & Bringing High-Paying Jobs to Central Virginia

2021, Updates From Phlow™

Last Year, HHS Awarded Phlow Corp. with a $354 Million Contract to Work with VCU in Strengthening the U.S. Domestic Pharmaceutical Supply Chain Source: U.S. Representative Abigail Spanberger RICHMOND, Va.–U.S. Representative Abigail Spanberger today toured the...

Medicare Should Require Hospitals to Buy American-Made Essential Generic Drugs

2021, Other News

Source: Inside Sources The COVID-19 pandemic has revealed America’s troubling dependence on overseas supply chains, especially from China. This is particularly evident when it comes to essential generic drugs—including sedatives and antibiotics—needed to treat...

Advanced Pharmaceutical Manufacturing Campus in Central Virginia Will Create 186 New Jobs in City of Petersburg

2021, Updates From Phlow™

Company to invest $124.5 million to establish new facility adjacent to Phlow Corporation Source: Governor Ralph Northam RICHMOND, Va.–(BUSINESS WIRE)–Governor Ralph Northam today announced that pharmaceutical manufacturer Civica Inc. (Civica) will invest...

Phlow Co-Founder Featured in Life Science Leader

2021, Updates From Phlow™

Source: Life Science Leader When I first saw the name Frank Gupton, Ph.D., it was on the agenda for a session I was attending at the 2016 ISPE conference. Listed as a professor at Virginia Commonwealth University (VCU), I expected his contribution to the panel to be...
« Older Entries
Next Entries »

Recent Posts

  • Phlow Corp. Achieves Completion of Full-Scale Demonstration of Succinylcholine Chloride Active Pharmaceutical Ingredient (API) Production at its U.S. Metric Ton Facility
  • Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America
  • Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
  • JPEO-CBRND, in Partnership with HHS, Utilizes Interagency Agreement to Contract with Phlow Corporation to Provide Medical Countermeasures
  • Phlow Observes 4th Annual National Essential Medicine Shortage Awareness Day, Reaffirms Commitment to Protecting America’s Medicine Cabinet

Recent Comments

No comments to show.

WHY THIS MATTERS
JOIN US

+1 (804) 207-4893

[email protected]

424 Hull St., Suite 400
Richmond, VA 23224

MEDIA INQUIRIES

STAY CONNECTED

  • Follow
  • Follow
  • Follow

To report an adverse event or product complaint associated with Phlow Drug Products, please call (844) 708-2982.

Privacy Policy | Consent Preferences | Additional Resources & Policies